Thursday, June 18, 2020 | 4:00 PM - 4:45 PM
Don’t miss this month at Precision Medicine Thursdays at Venture Café to hear Jennifer Silva and Jonathan Silva discuss an innovative technology that uses a 3D augmented reality (AR) platform featuring a holographic visualization of the patient’s actual anatomy “floating” over the patient to guide interventional procedures. The visualization is fully controllable “hands-free” by the clinician, providing an ergonomic breakthrough for the treatment and analysis of cardiac arrhythmias. They will discuss this transformative technology and their experience as academic entrepreneurs as well as the company they founded, SentiAR Inc., which is completing the final stages of FDA review for the first augmented reality solution for interventional procedures.
Patricia Salyer | salyerp@wustl.edu
Jennifer Silva, MD, a pediatric electrophysiologist at Washington University School of Medicine in St. Louis, treats children with abnormal heart rhythms. She has co-founded a startup company that is developing technology intended to help doctors see real-time 3D holograms of the heart during procedures to fix erratic heart rhythms.
Professor Jonathan Silva’s laboratory has created novel algorithms that predict whether patients will respond to class I anti-arrhythmic molecules. These predictions are based on machine learning approaches that leverage a deep understanding of drug interaction biophysics. His group also developed software to provide a holographic display to physicians who perform catheter ablations for arrhythmia. This software was recently tested in humans, and the results showed that physician accuracy was significantly improved with the display. A company that he co-founded, SentiAR Inc, is commercializing the technology.
No recent activity